CBR External Travel Awards: Earl W. Davie Symposium 2023 – Megan Barney
Megan Barney, MS Medical Student from the Oregon Health & Sciences University School of Medicine shares her experience at the 2023 Earl W. Davie Symposium.
Rolling Towards Wellness: CBR Members Lace Up for Skating!
On Thursday, February 22nd, we saw 23 CBR members at the UBC Thunderbird Arena for a fun afternoon of public drop-in skating and socializing.
The Discovery of New Sentinels on the Immune Watchtower for Cancer
In the latest study by the Jefferies lab, we delve into the intricate world of type-2 innate lymphoid cells (ILC2), specifically exploring their plasticity during tumour expansion .
Celebrating women and girls in science: PhD candidate Marie Johns reflects on her journey in STEM
In recognition of International Day of Women and Girls in Science, MSL spoke with Marie Johns, a PhD candidate in the Jefferies Lab.
CBR Spotlights Female Leaders for #WomenInScience 2024
For International Day of Women and Girls in Science 2024, we profiled 6 female leaders at the CBR. They share their stories and experiences with us!
CBR External Travel Awards: Earl W. Davie Symposium 2023 – Nicole Rhoads
Nicole Rhoads, Research Technician III from Bloodworks Research Institute shares her experience at the 2023 Earl W. Davie Symposium.
CBR External Travel Awards: Earl W. Davie Symposium 2023 – Sarah Stucky
Sarah Stucky, Research Coordinator from the University of Washington-Seattle shares her experience at the 2023 Earl W. Davie Symposium.
CBR External Travel Awards: Earl W. Davie Symposium 2023 – Mahsa Yazdanbaksh
Mahsa Yazdanbakhsh, PhD Student from the University of Alberta shares her experience at the 2023 Earl W. Davie Symposium.
Congratulations 2022-23 CBR Travel Award Recipients!
This past year, CBR was pleased to support 10 award recipients, who attended and presented at conferences and workshops around the globe.
Hotwire the Cure: Turning Cold Tumors Hot
Research by Dr. Julyanne Brassard, recently published in Frontiers in Oncology, highlights a promising new therapeutic target for ovarian cancer.